These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32775395)

  • 21. Role of Imaging in Diagnosis of a Rare Hepatosplenic Gamma Delta T-Cell Lymphoma during Pregnancy: A Case Report and Review of Literature.
    Youssef RRH; Elmahdy A; Kohla S; Ibrahim F; Sabry AS; Alobaidly A; Saloum N
    Case Rep Oncol; 2019; 12(3):935-943. PubMed ID: 31966031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
    Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
    Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival Analysis of Hepatosplenic T Cell Lymphoma: A Population-Based Study Using SEER.
    Li Y; Chen K; Zuo C; Zeng R; He Y; Chen X; Xiao L; Zhou H
    Int J Gen Med; 2021; 14():8399-8411. PubMed ID: 34819748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.
    Yabe M; Medeiros LJ; Tang G; Wang SA; Ahmed S; Nieto Y; Hu S; Bhagat G; Oki Y; Patel KP; Routbort M; Luthra R; Fanale MA; Bueso-Ramos CE; Jorgensen JL; Vega F; Chen W; Hoehn D; Konoplev S; Milton DR; Wistuba I; Li S; You MJ; Young KH; Miranda RN
    Am J Surg Pathol; 2016 May; 40(5):676-88. PubMed ID: 26872013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity.
    Ning ZQ; Li ZB; Newman MJ; Shan S; Wang XH; Pan DS; Zhang J; Dong M; Du X; Lu XP
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):901-9. PubMed ID: 22080169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study.
    Zhang W; Su L; Liu L; Gao Y; Wang Q; Su H; Song Y; Zhang H; Shen J; Jing H; Wang S; Cen X; Liu H; Liu A; Li Z; Luo J; He J; Wang J; O'Connor OA; Zhou D
    Cancer Biol Med; 2021 Mar; 18(3):841-8. PubMed ID: 33755379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.
    Prochazka V; Faber E; Raida L; Vondrakova J; Kucerova L; Jarosova M; Indrak K; Papajik T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):63-6. PubMed ID: 19365529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience.
    Han X; Zhang W; Zhou D; Ruan J; Duan M; Zhu T; Li J; Cai H; Cao X; Ouyang M
    J Int Med Res; 2017 Feb; 45(1):290-302. PubMed ID: 28222648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of histone deacetylase inhibitors in peripheral T-cell lymphoma: a systematic review and meta-analysis on prospective clinical trials.
    Yang P; Tao Y; Zhao A; Shen K; Li H; Wang J; Zhou H; Wang Z; Wang M; Qu Y; Zhang L; Zheng Y; Niu T
    Front Oncol; 2023; 13():1127112. PubMed ID: 37384289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
    Tey SK; Marlton PV; Hawley CM; Norris D; Gill DS
    Am J Hematol; 2008 Apr; 83(4):330-3. PubMed ID: 17876769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatosplenic alphabeta T cell lymphoma.
    Nagai Y; Ikegame K; Mori M; Inoue D; Kimura T; Shimoji S; Togami K; Tabata S; Kurata M; Imai Y; Matsushita A; Nagai K; Ogawa H; Takahashi T
    Int J Clin Oncol; 2010 Apr; 15(2):215-9. PubMed ID: 20217452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
    Martelli M; Vignetti M; Zinzani PL; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli MF; Calabresi F; Tura S; Mandelli F
    J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation.
    Prochazka V; Faber E; Raida L; Papajik T; Vondrakova J; Rusinakova Z; Kucerova L; Myslivecek M; Indrak K
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Mar; 155(1):63-9. PubMed ID: 21475380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metachronous mixed cellularity classical Hodgkin's lymphoma and T-cell leukemia/lymphoma: A case report.
    Dong Y; Deng LJ; Li MM
    World J Clin Cases; 2021 Sep; 9(27):8177-8185. PubMed ID: 34621878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Mechanism of Action of Histone Deacetylase Inhibitor Chidamide: Enhancing the Chemotaxis Function of Circulating PD-1(+) Cells From Patients With PTCL.
    Wei C; Hu S; Luo M; Chen C; Wang W; Zhang W; Zhou D
    Front Oncol; 2021; 11():682436. PubMed ID: 34141623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Case of Hepatosplentic T Cell Lymphoma - A Rare, Aggressive Tumor of the Young.
    Cingam S; Patel S; Koshy N
    J La State Med Soc; 2017; 169(2):49-50. PubMed ID: 28414669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating PD-1 (+) cells may participate in immune evasion in peripheral T-cell lymphoma and chidamide enhance antitumor activity of PD-1 (+) cells.
    Zhang W; Shen H; Zhang Y; Wang W; Hu S; Zou D; Zhou D
    Cancer Med; 2019 May; 8(5):2104-2113. PubMed ID: 30969023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
    Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review.
    Ochenrider MG; Patterson DJ; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):144-8. PubMed ID: 20371449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.